New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Simple test could lead to more personalized treatment of rare ovarian cancer

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl
Oncology January 29,2024
Simple test could lead to more personalized treatment of rare ovarian cancer

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl
Oncology January 29,2024
Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Oncology January 29,2024
Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers

by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Oncology January 29,2024
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Oncology January 29,2024
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Oncology January 29,2024
New study presents evidence for 'tough conversations' around racism in access to cancer care

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w
Oncology January 29,2024
New study presents evidence for 'tough conversations' around racism in access to cancer care

New study presents evidence for 'tough conversations' around racism in access to cancer care

by National Comprehensive Cancer NetworkCredit: Unsplash/CC0 Public DomainNew research in the November 2022 issue ofJNCCN—Journal of the National Comprehensive Cancer Networkhas examined w
Oncology January 29,2024
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Oncology January 29,2024
Using AI during cancer-screening results in more recommended controls

Using AI during cancer-screening results in more recommended controls

by Mathilde Coraline Aarvold Bakke,University of OsloGraphical abstract. Credit:Clinical Gastroenterology and Hepatology(2022). DOI: 10.1016/j.cgh.2022.08.022A polyp is a small growt
Oncology January 29,2024
Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainColorectal cancer is a leading cancer-related cause of death in the United States, ranking third in in
Oncology January 29,2024
Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

Targeted care reverses racial/ethnic health disparities in colon cancer screening, researchers find

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCredit: Pixabay/CC0 Public DomainColorectal cancer is a leading cancer-related cause of death in the United States, ranking third in in
Oncology January 29,2024
Study: Living in disadvantaged neighborhood shortens breast cancer survival

Study: Living in disadvantaged neighborhood shortens breast cancer survival

by Lori SolomonBreast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 inJAMA Network
Oncology January 29,2024
Study: Living in disadvantaged neighborhood shortens breast cancer survival

Study: Living in disadvantaged neighborhood shortens breast cancer survival

by Lori SolomonBreast cancer-specific survival is shorter in women from disadvantaged neighborhoods versus advantaged neighborhoods, according to a study published online April 21 inJAMA Network
Oncology January 29,2024
Drug combination provides a one-two punch attack against colorectal cancer

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Oncology January 29,2024
Drug combination provides a one-two punch attack against colorectal cancer

Drug combination provides a one-two punch attack against colorectal cancer

by National Cancer InstituteOn the left,SN38, the active metabolite of irinotecan, traps TOP1 on DNA, forming TOP1 cleavage complexes that are degraded upon their formation, as seen by the
Oncology January 29,2024
A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

byAlbert Einstein College of MedicineA new study inJAMA Oncologyfound that a simple antibacterial treatment prevents severe cases of radiation dermatitis (ARD): No patients in the tr
Oncology January 29,2024
A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

A simple antibacterial treatment can solve a severe skin problem caused by radiation therapy

byAlbert Einstein College of MedicineA new study inJAMA Oncologyfound that a simple antibacterial treatment prevents severe cases of radiation dermatitis (ARD): No patients in the tr
Oncology January 29,2024
Researchers identify a regulator of breast cancer development

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu
Oncology January 29,2024
Researchers identify a regulator of breast cancer development

Researchers identify a regulator of breast cancer development

by UT Southwestern Medical CenterBreast cancer stem cells (BCSCs) are responsible for breast carcinogenesis. Researchers' work reveals potential targets for killing BCSCs to prevent breast tu
Oncology January 29,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com